Kuwahara et al. demonstrated that PX can augment caspase 3/7 activity in HepG-2 hepatocellular carcinoma cells, leading to enhanced apoptosis and improved antitumor effectiveness [23]. Here, CASP3 is linked to hepatocellular carcinoma.